Adult respiratory distress syndrome complicating intravenous infusion of low-molecular weight dextran.
Respiratory failure is one of the most uncommon and serious adverse drug reactions. Low-molecular-weight-dextran (Dextran-40) is a useful adjunctive anti-platelet agent in the setting of coronary angioplasty and intracoronary stent placement. We report the occurrence of the adult respiratory distress syndrome following intravenous infusion of Dextran-40.
Taylor
M A
MA
Department of Cardiology, Deborah Heart and Lung Center, Browns Mills, NJ 08015.
DiBlasi
S L
SL
Bender
R M
RM
Santoian
E C
EC
Cha
S D
SD
Dennis
C A
CA
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D003324:Coronary Artery Disease / Q000628:therapy; D003911:Dextrans / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D011654:Pulmonary Edema / Q000139:chemically induced*; D012128:Respiratory Distress Syndrome / Q000139:chemically induced*
D003911:Dextrans